pharmaceutical sector Articles
-
Alliance and technology networks: an empirical study on technology learning
Patterns of alliance ties and patent citations, between firms in the chemical-pharmaceutical sector over a 13-year period, were mapped to draw alliance and technology networks in the industry. We then investigated how technology learning takes place in the networks. Learning was particularly high when the allies have had direct interorganisational ties, and when both allies have accessed the ...
-
A statistical examination of the integration of biotechnology in the Indian pharmaceutical sector
From the beginning of the 1970s a number of Indian pharmaceutical firms had invested in gaining technological competence without having "formal R&D centres"; and through efficient "reverse engineering" had slashed the prices of products otherwise sold by Western multinationals. However, their knowledge base was founded on the chemical technology of creating bulk drugs and ...
-
The pharmaceutical sector commited to technology to reduce the environmental footprint of covid-19
The COVID-19 pandemic seems to have entered its final stage, with fortunately very low numbers, both hospitalized and deceased. Its impact, however, is not limited to the health and social sphere. The massive use of medicines and sanitary material (wipes, gloves or disposable masks) is one of the most devastating side effects of COVID-19 due to its environmental damage when its waste goes to ...
-
The role of Knowledge Management in the pharmaceutical enterprise
In the knowledge intensive pharmaceutical sector, novelty and value are essential for corporate success. This paper discusses the requirements for, and the role of, effective Knowledge Management, as a means for business optimisation and improvement in terms of performance and competitiveness. The various types of knowledge resources are identified and major issues for both explicit/informational ...
-
Rising to the technological challenge: possibilities for integration of biotechnology in the Indian pharmaceutical industry
Presently, the Indian pharmaceutical industry ranks 12th in the world and its market is conservatively estimated to be $2.5 billion. Tracing the evolution of this industry, the paper first shows that Indian firms over the years had invested in gaining knowledge of the chemical technology of creating bulk drugs, and the top tier firms had greatly "learnt by doing", improving upon the ...
-
Conditions for the achievement of pharmaceutical innovation for sustainable development: lessons from India
This paper shows the post-TRIPS experience to be contradicting the overstated claim that "the adverse effect of TRIPS Agreement on prices of patented medicines would be adequately compensated by the benefits of technology transfer and domestic R&D". It argues that policymakers cannot continue to formulate their strategic interventions with an understanding that "strong IPRs are ...
-
Patents versus patients: reflections on this blatant patent regime
The paper centres on the 'patents versus patients' debate and delves into the challenges facing India's pharmaceutical sector with the advent of the World Trade Organization (WTO)-Trade-Related Aspects of Intellectual Property Rights (TRIPS) product patent regime. Considering the nation's commitments on international soil and the subsequent domestic legislations enacted to fulfil commitments made ...
-
Long–term value creation in the pharmaceutical sector: an event study analysis of big pharma stocks
We investigate the drivers of value creation in big pharmaceutical firms. We use a unique dataset of a total of 2,200 news items on research and development (R&D) progress announcements and dividend news of 25 largest pharmaceutical companies for the period 1998–2010. Our findings affirm the role of successful R&D as a driver of value creation in the long–run. This long term view of value ...
-
Comprehensive Insights into Native Porcine Pancreatin: A Versatile Enzyme Preparation
Native Porcine Pancreatin, an enzymatic mixture derived from the porcine pancreas, has emerged as a fundamental component in various industries due to its unique enzymatic composition. Comprising amylase, lipase, and protease enzymes, this preparation is celebrated for its multifaceted applications and plays an indispensable role in the pharmaceutical, food, and biotechnology sectors. In this ...
-
Removal of antibiotics and pharmaceutical residues in water urgent
According to the WHO, antimicrobial resistance (AMR) is one of the greatest threats to health and food safety. It is increasingly evident that antibiotics, resistant micro-organisms, and their resistance genes are spreading invisibly through water. It is important that we tackle AMR effectively in water too. Antibiotics and other medicines will continue to play a key role in our everyday lives, ...
-
Enzyme Engineering and Modification Technology Pioneers a Sustainable Future Across Industries
Enzymes, nature's molecular architects, have been at the heart of industrial processes for decades. Today, the dynamic field of Enzyme Engineering and Modification is driving these biocatalysts towards unprecedented capabilities, triggering a wave of transformative applications across diverse sectors. Decoding Enzyme Engineering Enzyme Engineering stands as a cornerstone of modern ...
-
Pharmaceutical and Medical Sector Waste Review Service
Pharmaceutical manufacturing plants generate a variety of waste streams throughout the production, supply and organisational processes. While the day-to-day activities are similar from one plant to the next, the actual processes used in pharmaceutical manufacturing vary widely. The pharmaceutical industry is highly competitive and many organisations are often unwilling to reveal details that ...
-
Fixing the paradigm for biopharmaceutical R&D: Where to start?
The basic thesis of this paper is that the R&D sector of the new medicines' business is experiencing evolutionary stress. Due to the failure of the regulatory framework and applied sciences to keep pace with advances in discovery, there is a bottleneck in the development phase of R&D. While improved process may help, there are still problems related to the products themselves, such as the need to ...
-
Evolving relations between the pharmaceutical industry and public sector research
The interface between the pharmaceutical industry and public sector research (PSR) is increasingly diverse, dynamic and complex. As the industry consolidates at the top end, it is also differentiating and fragmenting. A new layer of small focused-activity companies are emerging, many from PSR. This paper examines patterns of knowledge exchange between PSR and industry along the length of the ...
-
Enduramaxx registered on an Achilles community
nduramaxx is pleased to announce that they are now fully registered as a supplier on the Achilles UVDB Community (Utilities Vendor Database). Achilles UVDB is a business community for the UK utilities industry and major contractors enabling the sector to use the Achilles supplier pre-qualification system to manage risk and comply with EU procurement regulations. Achilles provides a fair, open ...
-
Genomics-based drug innovation: visions and commercial viability
This paper tracks the development of genomics between 1990 and 2005 principally within the US context and reviews that development with specific respect to early expectations of genomics-based pharmaceutical innovation, the initial claims made for it, and the realities of its current position. Emphasis is placed on relations between the genomics sector and its larger pharmaceutical and ...
-
10 Challenges that Pharmaceuticals face for Equipment Maintenance
Pharmaceutical is among the industries that have complex processes. It continuously requires new strategies to improve the ongoing operations, achieve business goals, and maintain competitiveness. One of the common mistakes they make while developing business strategies is not considering equipment maintenance. That’s why pharmaceutical companies face numerous challenges for their ...
-
Harnessing the Potential of Marine Polysaccharides as Valuable Resources
Source of Marine Polysaccharides Marine polysaccharides are primarily sourced from a diverse range of marine organisms that thrive in oceans and seas. Seaweeds are the primary and most abundant source of marine polysaccharides. Seaweeds with high polysaccharide content, such as red algae (Rhodophyta), brown algae (Phaeophyceae), and green algae (Chlorophyta), have been extensively studied for ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you